Big Pharma Hurts Maternal Health

Giving birth in America is nearly twice as deadly as doing so in Europe. Big Pharma is partly responsible, choking the 340B Drug Discount Program that helps fund maternity wards ...

Five Ways Big Pharma Can Be More Transparent

In recent years, drug companies have regularly touted the need for more information from hospitals participating in the 340B Drug Discount Program. Given the opaqueness of Big Pharma’s own ...

The Future of 340B Rests with Congress

Leading hospital trade groups recently announced they are willing to seek a legislative solution to update the 340B Drug Discount Program. The move, years in the making, is timely and ...

340B Winter Conference: In Comes the Pink Elephant

The Winter 340B Coalition conference was more like “Spring” from a timing perspective, and we associate springtime with new growth, vibrant colors, and hope for dark days to end and ...

The Craneware Group announces it supports and underwrites advocacy group 340B Matters

The Craneware Group (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today publicly announces it supports and underwrites the advocacy group 340B Matters. In 2016, guided by ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields